Hospital
ST. Louis Children's Hospital
ST. Louis Children's Hospital was paid $66.87M by Medicaid between Jan 2018 and Dec 2024, across 137 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoST. LOUIS CHILDREN'S HOSPITAL
SAINT LOUIS, MO 63110
SAINT LOUIS, MO 63110
33aNPI1992727663assigned 07/24/2006
33bProvider typePsychiatric Hospital
28Total paid$66.87M
24GClaims220,568
24DCodes billed137
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital providers in Missouri
Rank by total paid#1 of 12
Median peer was paid$408K
This provider vs. median164×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,339 | $20.85M | |
| 2019 | 31,587 | $17.54M | |
| 2020 | 22,987 | $6.32M | |
| 2021 | 32,771 | $1.60M | |
| 2022 | 38,931 | $7.52M | |
| 2023 | 28,804 | $7.38M | |
| 2024incomplete | 19,149 | $5.66M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 62,922 | 61,443 | $17.29M |
| Y7506 | 9.8% | 3,319 | 3,147 | $6.53M | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | 6.1% | 2,878 | 2,765 | $4.10M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.0% | 20,689 | 18,184 | $4.02M |
| A0425 | Ground mileage, per statute mile | 4.9% | 3,917 | 3,748 | $3.27M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.6% | 5,921 | 5,749 | $3.07M |
| X4011 | State-specific procedure code | 4.0% | 7,486 | 7,234 | $2.70M |
| J3490 | Unclassified drugs | 3.5% | 13,510 | 10,098 | $2.34M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.2% | 5,462 | 5,304 | $2.12M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2.8% | 3,442 | 3,408 | $1.86M |
| 80053 | Comprehensive metabolic panel | 2.2% | 12,374 | 10,996 | $1.49M |
| 92567 | 2.2% | 8,699 | 8,462 | $1.47M |
125 more codes
| 67311 | 2.1% | 691 | $1.43M | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.8% | 8,118 | $1.17M |
| 85045 | 1.7% | 2,797 | $1.14M | |
| 87631 | 1.6% | 2,406 | $1.04M | |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 4,232 | $1.00M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.4% | 4,457 | $957K |
| 95782 | 1.4% | 179 | $948K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.0% | 4,349 | $695K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 395 | $632K |
| 83020 | <1% | 646 | $524K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 168 | $510K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,353 | $453K |
| 95812 | <1% | 352 | $423K | |
| 87070 | <1% | 1,502 | $334K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,764 | $306K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 759 | $276K |
| 86900 | <1% | 336 | $236K | |
| 86901 | <1% | 336 | $235K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,675 | $234K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,593 | $230K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,063 | $212K |
| G0378 | Hospital observation service, per hour | <1% | 208 | $206K |
| 86850 | <1% | 295 | $203K | |
| 92582 | <1% | 630 | $173K | |
| 92555 | <1% | 441 | $154K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,850 | $150K |
| 92556 | <1% | 372 | $141K | |
| 76770 | <1% | 452 | $123K | |
| 81001 | <1% | 854 | $120K | |
| 73100 | <1% | 1,016 | $111K | |
| 77073 | <1% | 871 | $110K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,500 | $109K |
| 82977 | <1% | 1,577 | $109K | |
| 92552 | <1% | 207 | $104K | |
| 84439 | <1% | 1,321 | $98K | |
| 80076 | <1% | 315 | $94K | |
| 83516 | <1% | 246 | $89K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 624 | $84K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 82 | $81K |
| 82728 | <1% | 175 | $79K | |
| 73620 | <1% | 819 | $73K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 169 | $70K |
| 73070 | <1% | 359 | $67K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 555 | $60K |
| 82784 | <1% | 445 | $59K | |
| 92579 | <1% | 229 | $59K | |
| 72082 | <1% | 644 | $58K | |
| X4006 | <1% | 37 | $53K | |
| 72170 | <1% | 448 | $46K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,553 | $40K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 135 | $38K |
| 82570 | <1% | 314 | $37K | |
| 84156 | <1% | 106 | $37K | |
| 85027 | <1% | 134 | $35K | |
| 73090 | <1% | 296 | $34K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,286 | $33K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 26 | $33K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 39 | $30K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 65 | $29K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 362 | $28K |
| 81003 | <1% | 1,072 | $27K | |
| 73521 | <1% | 98 | $26K | |
| 86902 | <1% | 43 | $26K | |
| 97161 | <1% | 97 | $22K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 27 | $20K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,427 | $16K |
| 92585 | <1% | 12 | $15K | |
| X4003 | <1% | 298 | $14K | |
| 73590 | <1% | 134 | $14K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 74 | $13K |
| 86140 | <1% | 114 | $13K | |
| 85652 | <1% | 144 | $13K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 13 | $13K |
| 82248 | <1% | 463 | $12K | |
| 73140 | <1% | 113 | $11K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 23 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 130 | $10K |
| 81025 | <1% | 224 | $10K | |
| 80061 | Lipid panel | <1% | 106 | $9K |
| 74018 | <1% | 159 | $7K | |
| 92587 | <1% | 13 | $6K | |
| 87077 | <1% | 47 | $5K | |
| 73564 | <1% | 19 | $5K | |
| 92557 | <1% | 12 | $4K | |
| 80197 | <1% | 212 | $4K | |
| 77077 | <1% | 13 | $4K | |
| 74019 | <1% | 24 | $4K | |
| Y7508 | <1% | 12 | $4K | |
| 87536 | <1% | 30 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $3K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 266 | $3K |
| Y7510 | <1% | 15 | $3K | |
| 92133 | <1% | 43 | $3K | |
| 76000 | <1% | 24 | $3K | |
| 92250 | <1% | 12 | $2K | |
| 73560 | <1% | 31 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 41 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 40 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 38 | $2K |
| 73610 | <1% | 14 | $2K | |
| 73000 | <1% | 12 | $1K | |
| 73630 | <1% | 12 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $1K |
| 92018 | <1% | 12 | $1K | |
| 83735 | <1% | 235 | $1K | |
| 86364 | <1% | 55 | $899.53 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 24 | $850.76 |
| 83690 | <1% | 143 | $811.39 | |
| 86360 | <1% | 13 | $722.13 | |
| 83880 | <1% | 14 | $580.83 | |
| 86359 | <1% | 13 | $580.04 | |
| 87205 | <1% | 54 | $316.99 | |
| 83655 | <1% | 14 | $275.60 | |
| 84100 | <1% | 199 | $228.03 | |
| 87075 | <1% | 14 | $176.88 | |
| 83550 | <1% | 24 | $166.80 | |
| 83540 | <1% | 24 | $139.25 | |
| J7140 | <1% | 21 | $127.87 | |
| 87184 | <1% | 12 | $120.60 | |
| 86592 | <1% | 12 | $92.29 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 32 | $53.13 |
| 85610 | <1% | 15 | $36.23 | |
| 85660 | <1% | 34 | $34.16 | |
| 0000 | 0% | 20 | $0.00 | |
| 87102 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOLLO, TRISHA (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| ST. Louis Children's Hospital | Saint Louis, MO | $9K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.